PT - JOURNAL ARTICLE AU - Bragulat-Arévalo, Mireia AU - Ferrer-Cornet, Marta AU - Dux-Santoy, Lydia AU - Oliveró-Soldevila, Ruper AU - Garcia-Reyes, Marvin AU - Teixido-Tura, Gisela AU - Garrido-Oliver, Juan AU - Galian-Gay, Laura AU - Lopez-Gutierrez, Pere AU - Morales-Galán, Alberto AU - Catalá-Santarrufina, Alba AU - García Garzón, Jose Ramon AU - Martinez Esquerda, Noemi AU - Solsona, Javier AU - Ferreira-González, Ignacio AU - Bellmunt-Montoya, Sergi AU - Rodriguez-Palomares, Jose AU - Guala, Andrea TI - Validation and reproducibility of mapping positron emission tomography uptake in the aortic wall and thrombus AID - 10.1101/2024.07.30.24311215 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.30.24311215 4099 - http://medrxiv.org/content/early/2024/07/31/2024.07.30.24311215.short 4100 - http://medrxiv.org/content/early/2024/07/31/2024.07.30.24311215.full AB - INTRODUCTION Aortic aneurysms are prevalent diseases of the aorta, with limited knowledge about their aetiology, progression, and risk, and no effective pharmacological treatment. 18F-fluorodesoxyglucose Positron Emission Tomography (18F-FDG PET) provides molecular level information of glucose activity, serving as potential analogue of vascular inflammation, which may be relevant to improve knowledge and clinical management of aortic aneurysms. Nonetheless, current clinical assessment of 18F-FDG uptake presents several limitations.PURPOSE The aim of this study was to develop, test and validate an innovative aortic wall uptake mapping.METHODS PET/magnetic resonance (MR) data from 72 patients were acquired. The aortic lumen was segmented, and 9 anatomical landmarks were identified to create a standardised aortic lumen discretization including up to 80 patches. Black-blood MR images were used to guide thrombus segmentation if present, which was merged with lumen segmentation to generate a thoraco-abdominal aortic wall mask. This mask was then expanded by 1 to 5 mm in the inward and outward directions, resulting in an aortic wall volume of interest. Median and percentile 95th standard uptake value (SUV) was calculated on each aortic patch. A second observer performed the same analysis on 23 randomly selected patients for inter-observer reproducibility assessment. Validation was performed by comparisons with regional SUV measured by a nuclear medicine expert.RESULTS The technique was highly feasible, permitting the analysis of all 72 patients and in the 99.6% of aortic wall patches. The image analysis workflow was highly reproducible, resulting in Dice scores of 0.90 [0.57, 0.91] and 0.85 [0.78, 0.88] for aortic and thrombus segmentations, respectively, and in excellent co-localization for anatomical references (5.74 [3.62, 8.73] mm).The inter-observer reproducibility of aortic wall SUV mapping was excellent (ICC between 0.924 and 0.945), with limited differences with respect to aortic wall thickness and similar performances for SUV quantification in the thrombus. The validation of regional SUV values showed good agreement, with limited impact of aortic wall thickness values. A balance between reproducibility and accuracy was obtained with a volume of interest of 6 mm thickness.CONCLUSIONS An image analysis implementation based on multi-modality PET/MR data provides reproducible and accurate quantitative aortic wall 18F-FDG uptake maps. This approach may enable exploring local factors related to an inflammatory vascular state, with possible repercussions in clinical practice.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by funding from the Spanish Ministry of Science and Innovation (FORT23/00034, PLEC2021- 007664, RTC2019-007280-1), the Instituto de Salud Carlos III (PI19/01480) and la Caixa Foundation (LCF/BQ/PR22/11920008).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Vall d Hebron University Hospital Ethics committee and patients gave their written informed consentI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.